Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Equity: 2013-2024

Historic Return on Equity for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Dec 2024 value amounting to 0.22%.

  • Amphastar Pharmaceuticals' Return on Equity fell 9.00% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year decrease of 9.00%. This contributed to the annual value of 0.22% for FY2024, which is 2.00% down from last year.
  • According to the latest figures from FY2024, Amphastar Pharmaceuticals' Return on Equity is 0.22%, which was down 7.26% from 0.23% recorded in FY2023.
  • In the past 5 years, Amphastar Pharmaceuticals' Return on Equity ranged from a high of 0.23% in FY2023 and a low of 0.00% during FY2020.
  • Its 3-year average for Return on Equity is 0.21%, with a median of 0.22% in 2024.
  • In the last 5 years, Amphastar Pharmaceuticals' Return on Equity fell by 16bps in 2020 and then rose by 14bps in 2021.
  • Over the past 5 years, Amphastar Pharmaceuticals' Return on Equity (Yearly) stood at 0.00% in 2020, then grew by 14bps to 0.14% in 2021, then increased by 4bps to 0.18% in 2022, then climbed by 5bps to 0.23% in 2023, then declined by 2bps to 0.22% in 2024.